Skip to main content
Premium Trial:

Request an Annual Quote

Self-Injecting Stem Cells?

Using stem cells to treat type I diabetes is showing promise, says this news report. In this week’s issue of JAMA, scientists report preliminary results that giving diabetes patients their own nonmyeloablative hematopoietic stem cells after a course of immunosuppression could help treat newly diagnosed patients.

No word on how many patients this will help if they're required to correctly pronounce the name of the stem cells they need.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.